Understanding heart disease progression in COVID-19 patients
Cardiovascular Clinical Features and Cardiovascular Therapies in the Development, Progression and Outcome of Patients With SARS-Cov-2 Related Pneumonia
This study looks at how COVID-19 affects heart disease in hospitalized patients to see what factors might lead to worse outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT04606732 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify predictors of cardiovascular disease progression and mortality in patients hospitalized with COVID-19. It involves both retrospective and prospective data collection from patients with confirmed SARS-CoV-2 infections. The study analyzes patient characteristics, medical history, and treatment outcomes to determine factors associated with disease progression. Logistic analyses will be conducted to evaluate the relationship between these factors and patient mortality.
Who should consider this trial
Good fit: Ideal candidates are hospitalized patients over 18 years old with confirmed COVID-19.
Not a fit: Patients under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify at-risk patients and improve management strategies for cardiovascular complications in COVID-19.
How similar studies have performed: Other studies have explored cardiovascular implications of COVID-19, suggesting potential for significant findings in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: hospitalization for COVID-19 Exclusion Criteria: age \<18 years
Where this trial is running
Bologna
- Policlinico Sant'Orsola — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Olivia Manfrini, MD — DIMEC, Università di Bologna
- Study coordinator: Olivia Manfrini, MD
- Email: olivia.manfrini@unibo.it
- Phone: +393355612175
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.